Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 15 | 2024 | 5130 | 1.540 |
Why?
|
Polydeoxyribonucleotides | 4 | 2024 | 138 | 1.160 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1056 | 0.450 |
Why?
|
Metabolic Clearance Rate | 1 | 2013 | 361 | 0.420 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 693 | 0.420 |
Why?
|
Myelodysplastic Syndromes | 1 | 2022 | 1394 | 0.390 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2013 | 146 | 0.390 |
Why?
|
Melphalan | 2 | 2022 | 420 | 0.330 |
Why?
|
Antigens, CD20 | 1 | 2010 | 201 | 0.330 |
Why?
|
Thalidomide | 3 | 2024 | 884 | 0.300 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2021 | 1628 | 0.280 |
Why?
|
Paraproteinemias | 2 | 2022 | 246 | 0.270 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2022 | 3602 | 0.260 |
Why?
|
Dexamethasone | 3 | 2024 | 1927 | 0.260 |
Why?
|
Antineoplastic Agents | 5 | 2024 | 13630 | 0.230 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 231 | 0.210 |
Why?
|
Antibodies, Bispecific | 1 | 2023 | 191 | 0.190 |
Why?
|
Karyopherins | 1 | 2021 | 130 | 0.180 |
Why?
|
Endothelium, Vascular | 2 | 2024 | 4433 | 0.180 |
Why?
|
Antirheumatic Agents | 1 | 2010 | 1374 | 0.180 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 179 | 0.170 |
Why?
|
Hydrazines | 1 | 2021 | 224 | 0.170 |
Why?
|
Cardiac Tamponade | 1 | 2020 | 174 | 0.160 |
Why?
|
Oligopeptides | 1 | 2024 | 1187 | 0.160 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 349 | 0.140 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1454 | 0.140 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 854 | 0.140 |
Why?
|
Vasculitis | 1 | 2021 | 523 | 0.140 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2016 | 27 | 0.130 |
Why?
|
Triazoles | 1 | 2021 | 904 | 0.130 |
Why?
|
Immunotherapy | 3 | 2024 | 4642 | 0.130 |
Why?
|
Pericardium | 1 | 2020 | 675 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5649 | 0.110 |
Why?
|
Treatment Failure | 1 | 2019 | 2648 | 0.110 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9185 | 0.110 |
Why?
|
Vidarabine | 1 | 2013 | 336 | 0.100 |
Why?
|
Plasma Cells | 2 | 2016 | 591 | 0.100 |
Why?
|
Transplantation, Autologous | 3 | 2021 | 2116 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1745 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1588 | 0.090 |
Why?
|
Lymphoma, B-Cell | 1 | 2016 | 935 | 0.080 |
Why?
|
Humans | 24 | 2024 | 760621 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3539 | 0.080 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2010 | 237 | 0.070 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2007 | 49 | 0.070 |
Why?
|
Boronic Acids | 1 | 2010 | 914 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11712 | 0.060 |
Why?
|
Thymoma | 1 | 2007 | 187 | 0.060 |
Why?
|
Neutropenia | 1 | 2010 | 884 | 0.060 |
Why?
|
Pyrazines | 1 | 2010 | 1199 | 0.060 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.060 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.060 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 80 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8624 | 0.060 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 1007 | 0.050 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2007 | 664 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9276 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 583 | 0.050 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2021 | 24 | 0.050 |
Why?
|
Lymphoma | 1 | 2010 | 1898 | 0.050 |
Why?
|
Viral Tropism | 1 | 2021 | 102 | 0.040 |
Why?
|
Glucuronidase | 1 | 2021 | 202 | 0.040 |
Why?
|
Thrombotic Microangiopathies | 1 | 2021 | 124 | 0.040 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2021 | 221 | 0.040 |
Why?
|
Multiple Organ Failure | 1 | 2021 | 386 | 0.040 |
Why?
|
Graft vs Host Disease | 2 | 2021 | 3025 | 0.040 |
Why?
|
Thrombophilia | 1 | 2021 | 306 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2250 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2010 | 4742 | 0.030 |
Why?
|
Reticulocyte Count | 1 | 2016 | 36 | 0.030 |
Why?
|
Middle Aged | 7 | 2024 | 220352 | 0.030 |
Why?
|
Aged | 6 | 2024 | 169152 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1955 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9501 | 0.030 |
Why?
|
Cohort Studies | 2 | 2022 | 41335 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5253 | 0.030 |
Why?
|
Reticulocytes | 1 | 2016 | 288 | 0.030 |
Why?
|
Male | 9 | 2024 | 359744 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1889 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2022 | 2192 | 0.030 |
Why?
|
Incidence | 1 | 2013 | 21392 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1544 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2021 | 65017 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2895 | 0.030 |
Why?
|
Heparin | 1 | 2021 | 1652 | 0.030 |
Why?
|
DNA Damage | 1 | 2023 | 2442 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2021 | 2693 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2803 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2016 | 859 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2021 | 1056 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1599 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4810 | 0.030 |
Why?
|
Female | 7 | 2024 | 391270 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 16939 | 0.020 |
Why?
|
Adult | 5 | 2024 | 219994 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 29658 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 40165 | 0.020 |
Why?
|
Attitude to Health | 1 | 2020 | 2029 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25942 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3215 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13308 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2224 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6544 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6498 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6828 | 0.020 |
Why?
|
Interferon Regulatory Factors | 1 | 2010 | 260 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8056 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8552 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10181 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4446 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 1403 | 0.020 |
Why?
|
Bone Marrow | 1 | 2016 | 2912 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4897 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1720 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15687 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2010 | 1313 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3616 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3804 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3531 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5039 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8044 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3527 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3775 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 58741 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12965 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5794 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5870 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13502 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9411 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11481 | 0.010 |
Why?
|
United States | 1 | 2021 | 72461 | 0.010 |
Why?
|
Animals | 1 | 2024 | 167963 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_